Tag archive for ‘andexamet’
Portola Pharmaceuticals: Initiating Coverage with a Buy (PTLA, $40.05)
 Overview of Report I am initiating coverage of Portola Pharmaceuticals with a Buy and a 2021 price target of $426.This is an extensive initial report on Portola Pharmaceuticals that is organized into five parts: Investment Overview for Portola is a summary of the key investment issues. An investor only needs to read this section in […]